Booth #201
Israel’s first pure-play cannabis firm, Isracann is focused on becoming a premier, low-cost cannabis producer.
Isracann secured 3 farms in Israel with cultivation licenses totalling 580,000 sq. ft. – Excellent climate, Fantastic location.
Positioned in the cannabis research capital of the world, we have relationships with the research, scientific and medical community to identify opportunities and develop a pipeline of products and devices.
Isracann is targeting an undersupplied domestic market and anticipates near-term expansion to major European marketplaces.
Read lessSee Isracann BioSciences at the Cantech Investment Conference.